These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33909909)

  • 1. Tanshinone IIA enhances susceptibility of non-small cell lung cancer cells to NK cell-mediated lysis by up-regulating ULBP1 and DR5.
    Sun Y; Gong C; Ni Z; Hu D; Ng W; Zhu X; Wang L; Si G; Yan X; Zhao C; Yao C; Zhu S
    J Leukoc Biol; 2021 Aug; 110(2):315-325. PubMed ID: 33909909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
    Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
    Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR inhibitors enhanced the susceptibility to NK cell-mediated lysis of lung cancer cells.
    Kim H; Kim SH; Kim MJ; Kim SJ; Park SJ; Chung JS; Bae JH; Kang CD
    J Immunother; 2011 May; 34(4):372-81. PubMed ID: 21499124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
    Zhang YZ; Lai HL; Huang C; Jiang ZB; Yan HX; Wang XR; Xie C; Huang JM; Ren WK; Li JX; Zhai ZR; Yao XJ; Wu QB; Leung EL
    Phytomedicine; 2024 Jun; 128():155431. PubMed ID: 38537440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction.
    Bae JH; Kim SJ; Kim MJ; Oh SO; Chung JS; Kim SH; Kang CD
    Cancer Sci; 2012 Jan; 103(1):7-16. PubMed ID: 21951556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA inhibits lipopolysaccharide-induced MUC1 overexpression in alveolar epithelial cells.
    Zhang K; Wang J; Jiang H; Xu X; Wang S; Zhang C; Li Z; Gong X; Lu W
    Am J Physiol Cell Physiol; 2014 Jan; 306(1):C59-65. PubMed ID: 24153432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer.
    Hu D; Shen W; Gong C; Fang C; Yao C; Zhu X; Wang L; Zhao C; Zhu S
    J Cell Mol Med; 2021 Mar; 25(6):2900-2908. PubMed ID: 33506637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
    Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells.
    Kim SJ; Ha GH; Bae JH; Kim GR; Son CH; Park YS; Yang K; Oh SO; Kim SH; Kang CD
    Exp Cell Res; 2015 Jan; 330(2):451-459. PubMed ID: 25218028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.
    Siew YY; Neo SY; Yew HC; Lim SW; Ng YC; Lew SM; Seetoh WG; Seow SV; Koh HL
    Int Immunol; 2015 Dec; 27(12):621-32. PubMed ID: 26138671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of NK cell-mediated lysis of non-small lung cancer cells by nPKC activator, ingenol 3,20 dibenzoate.
    Gong C; Yao C; Xu Z; Ni Z; Zhu X; Wang L; Yan X; Zhou W; Zhu S
    Mol Immunol; 2017 Mar; 83():23-32. PubMed ID: 28092804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells.
    Lin JY; Ke YM; Lai JS; Ho TF
    Phytomedicine; 2015 Sep; 22(10):929-38. PubMed ID: 26321742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity.
    Terry S; Abdou A; Engelsen AST; Buart S; Dessen P; Corgnac S; Collares D; Meurice G; Gausdal G; Baud V; Saintigny P; Lorens JB; Thiery JP; Mami-Chouaib F; Chouaib S
    Cancer Immunol Res; 2019 Nov; 7(11):1789-1802. PubMed ID: 31488404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the Antitumor Mechanism of Tanshinone IIA In Vivo and In Vitro through the Regulation of PERK-ATF4-HSPA5 Pathway-Mediated Ferroptosis.
    Guo C; Zhao W; Wang W; Yao Z; Chen W; Feng X
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Sevoflurane on Natural Killer Group 2, Member D-Mediated Immune Response in Non-Small-Cell Lung Cancer: An In Vitro Study.
    Jeon S; Kim HK; Kwon JY; Baek SH; Ri HS; Choi HJ; Cho HR; Lee YS; Kim JY; Kim J; Bae J; Lee HJ
    Med Sci Monit; 2020 Nov; 26():e926395. PubMed ID: 33139690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.
    Zhao L; Wang WJ; Zhang JN; Zhang XY
    Asian Pac J Cancer Prev; 2014; 15(9):4039-44. PubMed ID: 24935593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
    Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY
    Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells.
    Panwong S; Wathikthinnakon M; Kaewkod T; Sawasdee N; Tragoolpua Y; Yenchitsomanus PT; Panya A
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.